Business, energy, technology, markets and global industry news from Business News Today
Pharma & Biotech

Lilly’s $40m commitment to IU aims to transform Alzheimer’s research and trials

Eli Lilly and Indiana University are launching a $40M clinical trial and Alzheimer’s research initiative in Indiana. See what it could mean for U.S. pharma.

Read More
Medical Devices & Diagnostics

How Medtronic’s surgical robotics push could reshape operating rooms nationwide

Medtronic’s Hugo robot gets FDA clearance for urology. Explore how it could reshape U.S. robotic surgery and challenge incumbent systems like da Vinci.

Read More
Medical Devices & Diagnostics

Can Medtronic and Abbott redefine insulin delivery with the Instinct-integrated MiniMed 780G?

Medtronic’s MiniMed 780G now ships in the U.S. with Abbott’s Instinct sensor. Explore how this launch could reshape CGM-insulin system competition.

Read More
Medical Devices & Diagnostics

Can embedded AI help Philips challenge GE and Siemens in imaging software?

Philips unveils AVW 16 and new AI integrations at RSNA 2025. Find out how its cloud-native platform strategy could reshape diagnostic imaging workflows.

Read More
Medical Devices & Diagnostics

Why Philips LumiGuide could disrupt image-guided therapy with real-time light-based 3D navigation

Philips expands LumiGuide AI 3D light-based navigation across US and Europe. Find out how it could reshape image-guided therapy without radiation.

Read More
Medical Devices & Diagnostics

Philips launches Verida: Is AI finally delivering clinical-grade spectral CT?

Philips launches Verida, the first AI-native detector-based spectral CT. Find out how it could redefine radiology workflows and cardiac diagnostics.

Read More
Medical Devices & Diagnostics

Philips bets on AI automation to solve cardiac MR access and staffing gaps

Find out how Philips’ new AI-powered cardiac MR innovations could transform access, speed, and diagnostic precision in cardiovascular imaging.

Read More
Pharma & Biotech

Can higher-dose Wegovy reshape the obesity treatment curve for Novo Nordisk?

Novo Nordisk’s semaglutide 7.2 mg dose aims to raise Wegovy’s weight loss impact. Learn how this could shift obesity treatment and reshape clinical norms.

Read More